Generex Provides Update to Pending 1:1 Stock Dividend

NEXT STORY
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
PREV STORY
ELIGARD® (Leuprolide Acetate) for Injectable Suspension Continues Growth Momentum With Securing Favorable Formulary Position as the Lowest WAC Priced, and Only Subcutaneously Administered Leuprolide Acetate for the Palliative Treatment of Advanced Prostate Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ELSALYS BIOTECH and the prestigious German cancer research institute DKFZ initiate the development of ELB021 in B-Cell leukemia with the support of EU

ELSALYS BIOTECH and the prestigious German cancer research institute DKFZ initiate the development of ...

author_avatar
NASDAQ Market News

TiGenix et Takeda annoncent l’autorisation d’Alofisel® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de Crohn en Europe

COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix et Takeda annoncent l'autorisation d'Alofisel® (darvadstrocel) ...

author_avatar
NASDAQ Market News

Aduro Biotech Appoints Aimee Luck Murphy as Vice President of Clinical Development and Operations

BERKELEY, Calif., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced ...

author_avatar
NASDAQ Market News